Korro Bio (KRRO) News Today $37.00 +0.02 (+0.05%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Korro Bio, Inc. (NASDAQ:KRRO) Short Interest UpdateKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 653,900 shares, an increase of 50.1% from the December 15th total of 435,500 shares. Based on an average daily trading volume, of 140,800 shares, the days-to-cover ratio is currently 4.6 days. Approximately 11.7% of the shares of the stock are short sold.January 17 at 9:49 PM | marketbeat.comKorro Bio’s RNA Editing Potential: A Buy Rating with Promising Catalysts and Commercial OpportunitiesJanuary 16 at 8:39 AM | markets.businessinsider.comPiper Sandler Sticks to Its Buy Rating for Korro Bio (KRRO)January 15 at 5:51 AM | markets.businessinsider.comKorro Bio announces initiation of dosing in its REWRITE study on KRRO-110January 13, 2025 | markets.businessinsider.comKorro Bio initiated with an Outperform at OppenheimerJanuary 10, 2025 | markets.businessinsider.comKorro initiated with Outperform into 2025 catalysts at OppenheimerJanuary 10, 2025 | markets.businessinsider.comOppenheimer Begins Coverage on Korro Bio (NASDAQ:KRRO)Oppenheimer started coverage on Korro Bio in a research note on Friday. They issued an "outperform" rating and a $155.00 target price on the stock.January 10, 2025 | marketbeat.comKorro to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | finance.yahoo.comKorro Bio, Inc. (NASDAQ:KRRO) Receives $142.17 Consensus PT from BrokeragesJanuary 7, 2025 | americanbankingnews.comKorro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of "Buy" from AnalystsShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have earned an average rating of "Buy" from the six brokerages that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The averaJanuary 4, 2025 | marketbeat.comState Street Corp Acquires 18,877 Shares of Korro Bio, Inc. (NASDAQ:KRRO)State Street Corp lifted its holdings in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 18.9% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 118,765 shares of the company's stock after buying an additional 18,877 shareDecember 31, 2024 | marketbeat.comKorro Bio: Still Too Long To Go... Just Keep Watching For Now (Rating Upgrade)December 23, 2024 | seekingalpha.comWellington Management Group LLP Makes New $436,000 Investment in Korro Bio, Inc. (NASDAQ:KRRO)Wellington Management Group LLP bought a new stake in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 13,052 shares of the company's stock, valued at approximatelyDecember 21, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Stake Trimmed by Fmr LLCFmr LLC lowered its stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 9.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 579,563 shares of the company's stock after selling 59,562 shares duringDecember 11, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Receives Average Recommendation of "Buy" from AnalystsShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have earned a consensus recommendation of "Buy" from the six brokerages that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to tDecember 10, 2024 | marketbeat.comVerition Fund Management LLC Sells 29,095 Shares of Korro Bio, Inc. (NASDAQ:KRRO)Verition Fund Management LLC trimmed its holdings in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 23.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 93,289 shares of the company's stock afterDecember 5, 2024 | marketbeat.comEventide Asset Management LLC Lowers Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO)Eventide Asset Management LLC reduced its stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 26.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 391,166 shares of the company's stock aNovember 29, 2024 | marketbeat.comMitchell Kapoor Reaffirms Buy Rating for Korro Bio Amid Promising Developments in KRRO-110 TreatmentNovember 23, 2024 | markets.businessinsider.comKorro secures approvals in Australia to commence AATD trial of KRRO-110November 23, 2024 | msn.comKorro Bio (NASDAQ:KRRO) Trading 9.3% Higher - Still a Buy?Korro Bio (NASDAQ:KRRO) Trading Up 9.3% - What's Next?November 22, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $115.00 price target on shares of Korro Bio in a research report on Friday.November 22, 2024 | marketbeat.comKorro Bio receives HREC approval, CTN clearance to initiate Phase 1/2a studyNovember 21, 2024 | markets.businessinsider.comKorro to Participate in Upcoming Investor ConferencesNovember 21, 2024 | globenewswire.comKorro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin DeficiencyNovember 21, 2024 | globenewswire.comJones Trading Initiates Coverage of Korro Bio (KRRO) with Buy RecommendationNovember 19, 2024 | msn.comKorro Bio initiated with a Buy at JonesResearchNovember 18, 2024 | markets.businessinsider.comKorro Bio: Buy Rating Backed by Innovative RNA Editing Focus and Strategic PartnershipsNovember 18, 2024 | markets.businessinsider.comKorro Bio FY2024 EPS Forecast Increased by HC WainwrightKorro Bio, Inc. (NASDAQ:KRRO - Free Report) - HC Wainwright increased their FY2024 earnings per share estimates for Korro Bio in a report released on Wednesday, November 13th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($9.49) per share for the year, up fNovember 18, 2024 | marketbeat.comWilliam Blair Has Positive View of Korro Bio FY2024 EarningsKorro Bio, Inc. (NASDAQ:KRRO - Free Report) - Equities research analysts at William Blair boosted their FY2024 earnings estimates for Korro Bio in a note issued to investors on Wednesday, November 13th. William Blair analyst M. Minter now anticipates that the company will post earnings of ($9.80)November 18, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of "Buy" from AnalystsKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) has been given an average rating of "Buy" by the six ratings firms that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company.November 15, 2024 | marketbeat.comKorro to Present at the Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comKorro Bio’s Promising KRRO-110 Developments and Strong Financial Position Justify Buy RatingNovember 14, 2024 | markets.businessinsider.comKorro Bio’s Progress and Financial UpdatesNovember 14, 2024 | tipranks.comKorro Bio (NASDAQ:KRRO) Earns "Outperform" Rating from William BlairWilliam Blair reissued an "outperform" rating on shares of Korro Bio in a research report on Wednesday.November 13, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) CFO Vineet Agarwal Sells 800 SharesNovember 13, 2024 | insidertrades.comKorro Bio (NASDAQ:KRRO) Stock Price Up 10.9% - Here's What HappenedKorro Bio (NASDAQ:KRRO) Trading 10.9% Higher - Here's What HappenedNovember 7, 2024 | marketbeat.comKorro Bio’s Promising Regulatory and Preclinical Advances Earn a Buy Rating from Analyst Mitchell KapoorNovember 6, 2024 | markets.businessinsider.comKorro Bio (KRRO) Gets a Buy from Piper SandlerNovember 4, 2024 | markets.businessinsider.comKorro Bio announces regulatory filing for initiation of KRRO-110November 4, 2024 | markets.businessinsider.comKorro Bio (NASDAQ:KRRO) Shares Gap Down - Should You Sell?Korro Bio (NASDAQ:KRRO) Shares Gap Down - Here's What HappenedNovember 4, 2024 | marketbeat.comKorro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory BoardNovember 4, 2024 | globenewswire.comKorro Bio (NASDAQ:KRRO) Trading Down 5.1% - Time to Sell?Korro Bio (NASDAQ:KRRO) Trading Down 5.1% - Should You Sell?October 28, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Sees Unusually-High Trading Volume - What's Next?Korro Bio (NASDAQ:KRRO) Sees Strong Trading Volume - Should You Buy?October 23, 2024 | marketbeat.comKorro Bio initiated with a Strong Buy at Raymond JamesOctober 22, 2024 | markets.businessinsider.comRaymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy RecommendationOctober 22, 2024 | msn.comKorro Bio price target raised to $105 from $95 at RBC CapitalOctober 22, 2024 | markets.businessinsider.comKorro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.October 21, 2024 | investors.comRoyal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00Royal Bank of Canada boosted their target price on Korro Bio from $95.00 to $105.00 and gave the company an "outperform" rating in a research report on Monday.October 21, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by BrokeragesShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price targetOctober 21, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond JamesRaymond James initiated coverage on shares of Korro Bio in a research note on Monday. They set a "strong-buy" rating and a $153.00 price objective for the company.October 21, 2024 | marketbeat.com Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address KRRO Media Mentions By Week KRRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRRO News Sentiment▼0.300.72▲Average Medical News Sentiment KRRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRRO Articles This Week▼62▲KRRO Articles Average Week Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Schrödinger News Xencor News Ardelyx News Nurix Therapeutics News Kiniksa Pharmaceuticals News Arcus Biosciences News Ocular Therapeutix News Maravai LifeSciences News Arvinas News Praxis Precision Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRRO) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
